Source: Annual Congress 2002 - Airway epithelial cell activation, proliferation and differentiation



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Yamagata, T. Yamagata, T. Nishimoto, M. Nakanishi, T. Hirano, K. Matsunaga, H. Nakanishi, Y. Minakata, M. Mune, S. Yukawa (Wakayama, Japan). The mechanism of the inhibition of epithelial sodium channel by tumor necrosis factor-alpha in alveolar type II epithelial cells. Eur Respir J 2002; 20: Suppl. 38, 3533

Member's Comments

No comment yet.

Related content which might interest you: The inhibition of amiloride-sensitive current by tumor necrosis factor-alpha in alveolar type II epithelial cells and its signalling mechanism Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Mechanism of epithelial Na+ channel (ENaC) inhibition by hypoxia in alveolar epithelial cells Source: Annual Congress 2012 - New insights into airway epithelial cell physiology Year: 2012 Activation of alveolar fluid reabsorption in rat lung by tumor necrosis factor and terbutaline is triggered by different mechanisms Source: Eur Respir J 2004; 24: Suppl. 48, 452s Year: 2004 Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002 Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Modulation of NOS2 expression in co-cultures of human alveolar epithelial cells type II and alveolar macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001 The effect of vascular endothelial growth factor (VEGF) on primary human cultured type 2 alveolar epithelial (AE2) cell proliferation Source: Annual Congress 2004 - Cellular injury and repair in the lung Year: 2004 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 The impact of interleukin-2 on the regulation of epithelial sodium channel in A549 cells Source: Eur Respir J 2004; 24: Suppl. 48, 554s Year: 2004 Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Physiomer(R) reduces the chemokine interleukin-;8 production by activated human respiratory epithelial cells Source: Eur Respir J 2001; 18: 661-666 Year: 2001 In vivo blockade of KCa3.1 ion channel alleviates ER stress in type II alveolar epithelial cells and macrophages in pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Effect of in vivo blockade of the KCa3.1 ion channel on type II alveolar epithelial cell turnover in pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Wnt11 inhibits epithelial-mesenchymal transition induced by TGFb1 in human type II alveolar epithelial cells Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Anti-inflammatory effect of adenovirus-mediated IκBα overexpression in respiratory epithelial cells Source: Eur Respir J 2001; 18: 801-809 Year: 2001 Hyperosmotic induction of IL-8 in bronchial epithelial cells is cell volume dependent Source: Eur Respir J 2001; 18: Suppl. 33, 407s Year: 2001 PP126 – RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: ERS Lung Science Conference 2021 Year: 2021 RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Protein S inhibits the secretion of inflammatory cytokines from alveolar epithelial cells Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008